Medicine
Loargys 5 mg/mL injection
Loargys 5 mg/mL injection is a prescription medicine containing Pegzilarginase for intravenous, subcutaneous use, marketed by Immedica Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2 °C to 8 °C (36 °F to 46 °F) in the original carton to…
Key facts
- Active ingredient (INN)
- Pegzilarginase
- Brand
- Loargys
- Strength
- 5 mg/mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Marketing authorisation holder
- Immedica Pharma
- Manufacturer
- Immedica Pharma
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2 °C to 8 °C (36 °F to 46 °F) in the original carton to protect from light. Do not freeze. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A16AB24 Pegzilarginase
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 March 2026
- Identifiers
- RxCUI 2738655, 2738662, 2738664 +1DailyMed set ID d5ceabf2-43a0-4746-9371-d98a39cf6cfcNDC 81583-105Application BLA761211
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
No pack sizes are recorded. Pack size and quantity are confirmed on the quote.
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pegzilarginase
Clinical summary
Pegzilarginase is a prescription medicine indicated for the treatment of hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1-D), in conjunction with dietary protein restriction. MedsAcross supplies Pegzilarginase for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PegzilarginaseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Loargys prescribing information (Immedica Pharma) · U.S. National Library of Medicine, DailyMed
- Loargys: European public assessment report (EPAR) · European Medicines Agency
Need Loargys 5 mg/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.